AZN Gets Speedy Nod, RBP-6000 Just One Step Away From Approval, STML Soars

Today's Daily Dose brings you news about Akcea's AKCEA-APOCIII-LRx study results; FDA clearance of modifications in Avinger's Pantheris Lumivascular atherectomy system; accelerated approval of AstraZeneca's Calquence for mantle cell lymphoma; Catalyst Pharma's clinical trial catalyst to watch out for and FDA panel recommendation of Indivior's RBP-6000.

from RTT - Biotech http://ift.tt/2iQTHSo
via IFTTT